Sideline Gold on Fe...
Health Care: Health Services
Biolase Inc (BIOL: NASDAQ)
$3.98 -0.30 | -7.01%
06/18/13 - 04:00 PM ET
TheStreet Ratings Grade for BIOL
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.00 | 1.00 | 1.00 | 1.00 |
Portfolios with BIOL
- Portfolio NameUser Type
- UserJaheer
Latest BIOL Headlines from TheStreet
- Biolase's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.09.12 | 01:08 am
Press Releases for BIOL
Partner Headlines for BIOL
- BIOLASE Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 05.07.13 | 06:05 am
- Morning Market Movers - Benzinga 10.03.12 | 09:10 am
- BIOLASE Comments on Recent Market Activity; Reiterates Guidance - Benzinga 06.22.12 | 01:06 pm
